InflaRx N.V annual r&d spending
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
InflaRx N.V R&D Spending Growth & History (IFRX)
InflaRx N.V's r&d spending was €25.7M for fiscal 2025.
View full InflaRx N.V company overviewInflaRx N.V annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €25.7M | −€9.6M | −27.27% |
| 2024 | 2024-12-31 | €35.4M | −€5.7M | −13.80% |
| 2023 | 2023-12-31 | €41.0M | €3.5M | +9.32% |
| 2022 | 2022-12-31 | €37.5M | €1.8M | +5.12% |
| 2021 | 2021-12-31 | €35.7M | €10.0M | +38.99% |
| 2020 | 2020-12-31 | €25.7M | −€18.9M | −42.39% |
| 2019 | 2019-12-31 | €44.6M | €19.6M | +78.13% |
| 2018 | 2018-12-31 | €25.0M | €10.6M | +73.63% |
| 2017 | 2017-12-31 | €14.4M | €9.1M | +173.11% |
| 2016 | 2016-12-31 | €5.3M | €1.8M | +51.75% |
| 2015 | 2015-12-31 | €3.5M | — | — |
InflaRx N.V quarterly r&d spending
Q2.18
Q2.19
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €4.7M | −€2.5M | −34.21% |
| Q1 2026 | 2026-03-31 | €4.2M | — | — |
| Q4 2025 | 2025-12-31 | €5.3M | — | — |
| Q3 2025 | 2025-09-30 | €6.2M | — | — |
| Q2 2025 | 2025-06-30 | €7.2M | −€2.8M | −28.09% |
| Q2 2024 | 2024-06-30 | €10.0M | −€902,725 | −8.27% |
| Q2 2023 | 2023-06-30 | €10.9M | −€261,363 | −2.34% |
| Q2 2022 | 2022-06-30 | €11.2M | −€118,312 | −1.05% |
| Q2 2021 | 2021-06-30 | €11.3M | — | — |
| Q2 2019 | 2019-06-30 | €12.5M | €7.5M | +148.40% |
| Q2 2018 | 2018-06-30 | €5.0M | — | — |
InflaRx N.V r&d spending trends
Over the last five fiscal years, InflaRx N.V's r&d spending increased from €25.7M to €25.7M, a change of €36,648. The latest reported quarter, Q2 2026, shows €4.7M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InflaRx N.V source filings ↗